Sox4 null mice e12.5 pancreas - Study GBCO2944
Genomics Study Specifications
| Study Name | Sox4 null mice e12.5 pancreas | ||
|---|---|---|---|
| Contact Name | Michael German (University of California, San Francisco) | ||
| Publication | http://www.ncbi.nlm.nih.gov/pubmed/16306355 | ||
| My Strategies | Return to My Strategies page | ||
| Classification | Pancreas development and growth | ||
| Links | |||
| BCBC Release Date | January 31, 2007 | ||
| Public Release Date | January 31, 2007 | ||
| Citation | Wilson ME, Yang KY, Kalousova A, Lau J, Kosaka Y, Lynn FC, Wang J, Mrejen C, Episkopou V, Clevers HC, German MS. The HMG box transcription factor Sox4 contributes to the development of the endocrine pancreas. Diabetes. 2005. 54:3402-9 | ||
| Synopsis |
The purpose of this experiment was to assess global changes in gene expression pattern in the pancreas from Sox4-/- embryos vs. pancreas from Sox4 wild-type embryos at embryonic day 12.5. [Sox4 gene knock-out (Schilham, M. W. et al. (1996) Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4. Nature 380, 711-4.)]
Investigate the role of Sox transcription factors in
the development of the pancreas.
Temporal expression (e10.5 - e16.5) of Sox
factors were followed using TaqMan RT-PCR. Sox2 and sox4 were investigated
further. Sox2-lacZ knock-in mice were harvested (e9.5, e10.5,
e16.5) and stained for beta-galactosidase actvitiy and for pdx1. Sox4 expression was monitored in adult
mice by in situ hybridization and immunofluorescent
staining. Developing pancreas was examined up to e12.5 in Sox4 -/-
mice by morphology and immunohistochemical staining; pancreatic
explants from e11.5 were used to follow further development. Microarrays based on the FANTOM1 clone set and
selected additional clones were hybridized with labeled amplified
RNA from separate pools of sox4-/- and sox4+/+ pancreatic buds (2
each from 3 independent amplifications).
Sox 2, 11, and 12 mRNAs were found at
e10.5 but then declined with modest levels of sox12 persisting in
islets. Sox4 and sox9 had peaks after the secondary transition
(e13) and sox4 and sox13 mRNA levels were
high in islets. Sox2 expression was specifically excluded from the
pancreatic buds. In contrast, Sox4 was detected broadly in the
early pancreatic buds and eventually became restricted to the
nuclei of all islet cells in the adult mouse. Microarray studies
detected reduction in sox4-/- pancreatic buds for both ins1 and ins2, Nkx6.1, peroxiredoxin 2,
and glutathione peroxidase 1
mRNAs. Increases were found in the mutants for Sox11, Neurogenin3, and NeuroD1
mRNAs.
Sox2-expressing stems cells are rare or do not
exist in the mouse pancreas. By contrast, Sox4 is required for the
proper expansion of the endocrine cell population, especially beta
cells, after the secondary transition.
|
||
| Platform types | Expression, Expression microarray | ||
| Platforms |
Show platform UCSF-MMC-Fantom
|
||
| Study Design Type |
|
||
| Study Factors | Show study factors | ||
| Study Assays | Show study assays | ||
Access to Study Data
This Study Data is publicly available to all users.
Gene List(s)
Loading...
Repositories
| German Lab | |
|---|---|
|
|
Stock #: Not provided Availability Notes: Not provided |
Comments
There are no comments for this entry.
Access Status
Request this Resource
Resource Tags
glutathione peroxidase 1, Gpx1, Ins1, Ins2, insulin I, insulin II, Neurod1, Neurog3, neurogenic differentiation 1, neurogenin 3, NK6 homeobox 1, Nkx6-1, Nkx6.1, pancreatic and duodenal homeobox 1, Pdx1, peroxiredoxin 2, Prdx2, Sox11, Sox12, Sox13 SRY-box containing gene 13, Sox2, Sox4, Sox9, SRY-box containing gene 11, SRY-box containing gene 12, SRY-box containing gene 2, SRY-box containing gene 4, SRY-box containing gene 9, UCSF-MMC-Fantom
Resource History & Actions
Related resources
Loading...

Biomaterials Graph